Decreased expression of SCUBE2 is associated with progression and prognosis in colorectal cancer

Song,Qi; Li,Chuanwei; Feng,Xiaodong; Yu,Ailian; Tang,Huamei; Peng,Zhihai; Wang,Xuechun

doi:10.3892/or.2015.3790

Decreased expression of SCUBE2 is associated with progression and prognosis in colorectal cancer

Authors:
- Qi Song
- Chuanwei Li
- Xiaodong Feng
- Ailian Yu
- Huamei Tang
- Zhihai Peng
- Xuechun Wang
View Affiliations

Affiliations: Department of Pathology, Taishan Medical University, Taian, Shandong, P.R. China, Department of Etiology, Taishan Medical University, Taian, Shandong, P.R. China, Department of Pathology, Shanghai Jiaotong University Affiliated First People's Hospital, Shanghai, P.R. China, Department of General Surgery, Shanghai Jiaotong University Affiliated First People's Hospital, Shanghai, P.R. China
Published online on: February 9, 2015 https://doi.org/10.3892/or.2015.3790
Pages: 1956-1964

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Signal peptide-CUB-epidermal growth factor-like domain-containing protein 2 (SCUBE2), a member of the SCUBE protein family, is a secreted and membrane-associated multi-domain glycoprotein. SCUBE2 is known as a novel tumor suppressor and a useful prognostic marker in breast cancer. In the present study, we investigated the expression (including mRNA and protein levels) of SCUBE2 in colorectal cancer (CRC) and adjacent normal tissues, using quantitative real-time PCR, western blot analysis and immunohistochemistry on a tissue microarray. Upregulation of SCUBE2 was achieved by transient transfection in RKO cell lines, and the effects of SCUBE2 on tumor proliferation, invasion, migration and apoptosis were evaluated by a series of functional experiments. The results indicated that SCUBE2 expression was decreased at the transcriptional and translational levels in CRC tissues and significantly associated with clinical stage, the depth of tumor invasion, lymph‑node metastasis, distant metastasis and histological grade. Patients with SCUBE2‑positive tumors had a lower recurrence rate and better survival than patients with SCUBE2-negative tumors. Moreover, upregulation of SCUBE2 had a limited effect on cell apoptosis but significantly inhibited tumor cell proliferation, migration and invasion in vitro. In conclusion, SCUBE2 plays an important role in suppressing CRC progression and prognosis. Our findings suggested that SCUBE2 may serve as a novel tumor suppressor and a potential therapeutic target for CRC patients.

View Figures

View References

1	Siegel R, Ma J, Zou Z and Jemal A: Cancer statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
2	Siegel R, Desantis C and Jemal A: Colorectal cancer statistics, 2014. CA Cancer J Clin. 64:104–117. 2014. View Article : Google Scholar : PubMed/NCBI
3	Fearon ER: Molecular genetics of colorectal cancer. Annu Rev Pathol. 6:479–507. 2011. View Article : Google Scholar
4	Yang RB, Ng CK, Wasserman SM, et al: Identification of a novel family of cell-surface proteins expressed in human vascular endothelium. J Biol Chem. 277:46364–46373. 2002. View Article : Google Scholar : PubMed/NCBI
5	Wu BT, Su YH, Tsai MT, Wasserman SM, Topper JN and Yang RB: A novel secreted, cell-surface glycoprotein containing multiple epidermal growth factor-like repeats and one CUB domain is highly expressed in primary osteoblasts and bones. J Biol Chem. 279:37485–37490. 2004. View Article : Google Scholar : PubMed/NCBI
6	Hollway GE, Maule J, Gautier P, et al: Scube2 mediates Hedgehog signalling in the zebrafish embryo. Dev Biol. 294:104–118. 2006. View Article : Google Scholar : PubMed/NCBI
7	Tsai MT, Cheng CJ, Lin YC, et al: Isolation and characterization of a secreted, cell-surface glycoprotein SCUBE2 from humans. Biochem J. 422:119–128. 2009. View Article : Google Scholar : PubMed/NCBI
8	Cheng CJ, Lin YC, Tsai MT, et al: SCUBE2 suppresses breast tumor cell proliferation and confers a favorable prognosis in invasive breast cancer. Cancer Res. 69:3634–3641. 2009. View Article : Google Scholar : PubMed/NCBI
9	Lin YC, Chen CC, Cheng CJ and Yang RB: Domain and functional analysis of a novel breast tumor suppressor protein, SCUBE2. J Biol Chem. 286:27039–27047. 2011. View Article : Google Scholar : PubMed/NCBI
10	Rmali KA, Puntis MC and Jiang WG: Tumour-associated angio-genesis in human colorectal cancer. Colorectal Dis. 9:3–14. 2007. View Article : Google Scholar
11	Najib S, Kowalski-Chauvel A, Do C, Roche S, Cohen-Jonathan-Moyal E and Seva C: Progastrin a new pro-angiogenic factor in colorectal cancer. Oncogene. Aug 11–2014.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
12	Hu X, Lai D, Chen W, et al: Differential expression profiles of the Hedgehog signaling pathway between microsatellite-stable and microsatellite-unstable colorectal cancers. Mol Med Rep. 4:873–877. 2011.PubMed/NCBI
13	Wang H, Li YY, Wu YY and Nie YQ: Expression and clinical significance of hedgehog signaling pathway related components in colorectal cancer. Asian Pac J Cancer Prev. 13:2319–2324. 2012. View Article : Google Scholar : PubMed/NCBI
14	Sánchez-Navarro I, Gamez-Pozo A, Pinto A, et al: An 8-gene qRT-PCR-based gene expression score that has prognostic value in early breast cancer. BMC Cancer. 10:3362010. View Article : Google Scholar : PubMed/NCBI
15	Lin YC, Lee YC, Li LH, Cheng CJ and Yang RB: Tumor suppressor SCUBE2 inhibits breast-cancer cell migration and invasion through the reversal of epithelial-mesenchymal transition. J Cell Sci. 127:85–100. 2014. View Article : Google Scholar
16	Skrzypczak M, Lattrich C, Häring J, Schüler S, Ortmann O and Treeck O: Expression of SCUBE2 gene declines in high grade endometrial cancer and associates with expression of steroid hormone receptors and tumor suppressor PTEN. Gynecol Endocrinol. 29:1031–1035. 2013. View Article : Google Scholar : PubMed/NCBI
17	Penney KL, Sinnott JA, Fall K, et al: mRNA expression signature of Gleason grade predicts lethal prostate cancer. J Clin Oncol. 29:2391–2396. 2011. View Article : Google Scholar : PubMed/NCBI
18	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2^−ΔΔ^C^_T method. Methods. 25:402–408. 2001. View Article : Google Scholar
19	Li DW, Tang HM, Fan JW, et al: Expression level of Bmi-1 onco-protein is associated with progression and prognosis in colon cancer. J Cancer Res Clin Oncol. 136:997–1006. 2010. View Article : Google Scholar
20	Creanga A, Glenn TD, Mann RK, Saunders AM, Talbot WS and Beachy PA: Scube/You activity mediates release of dually lipid-modified Hedgehog signal in soluble form. Genes Dev. 26:1312–1325. 2012. View Article : Google Scholar : PubMed/NCBI
21	Kawakami A, Nojima Y, Toyoda A, et al: The zebrafish-secreted matrix protein you/scube2 is implicated in long-range regulation of hedgehog signaling. Curr Biol. 15:480–488. 2005. View Article : Google Scholar : PubMed/NCBI
22	Yang M, Guo M, Hu Y and Jiang Y: Scube regulates synovial angiogenesis-related signaling. Med Hypotheses. 81:948–953. 2013. View Article : Google Scholar : PubMed/NCBI
23	Abba MC, Hu Y, Sun H, et al: Gene expression signature of estrogen receptor α status in breast cancer. BMC Genomics. 6:372005. View Article : Google Scholar
24	Parris TZ, Danielsson A, Nemes S, et al: Clinical implications of gene dosage and gene expression patterns in diploid breast carcinoma. Clin Cancer Res. 16:3860–3874. 2010. View Article : Google Scholar : PubMed/NCBI
25	Sørlie T, Wang Y, Xiao C, et al: Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms. BMC Genomics. 7:1272006. View Article : Google Scholar : PubMed/NCBI
26	Sørlie T, Perou CM, Tibshirani R, et al: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA. 98:10869–10874. 2001. View Article : Google Scholar : PubMed/NCBI
27	Calza S, Hall P, Auer G, et al: Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients. Breast Cancer Res. 8:R342006. View Article : Google Scholar : PubMed/NCBI
28	Parris TZ, Aziz L, Kovacs A, et al: Clinical relevance of breast cancer-related genes as potential biomarkers for oral squamous cell carcinoma. BMC Cancer. 14:3242014. View Article : Google Scholar : PubMed/NCBI